These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 16351680

  • 1. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
    Kastelein JJ, Sankatsing RR.
    Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
    [Abstract] [Full Text] [Related]

  • 2. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
    Vaverková H.
    Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178
    [Abstract] [Full Text] [Related]

  • 3. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS, Mikhailidis DP.
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [Abstract] [Full Text] [Related]

  • 4. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [Abstract] [Full Text] [Related]

  • 5. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.
    J Am Coll Cardiol; 2008 Apr 22; 51(16):1564-72. PubMed ID: 18420099
    [Abstract] [Full Text] [Related]

  • 6. Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin.
    Farnier M.
    Fundam Clin Pharmacol; 2007 Nov 22; 21 Suppl 2():27-8. PubMed ID: 18001317
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Co-administration of ezetimibe and simvastatin in acute myocardial infarction.
    Chenot F, Montant PF, Marcovitch O, Blaimont M, de Meester A, Descamps OS.
    Eur J Clin Invest; 2007 May 22; 37(5):357-63. PubMed ID: 17461981
    [Abstract] [Full Text] [Related]

  • 9. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R, Goldberg AC.
    Endocrinol Metab Clin North Am; 2009 Mar 22; 38(1):79-97. PubMed ID: 19217513
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec 22; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 12. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M, Balcerak M, Chojnowska-Jezierska J.
    Pol Merkur Lekarski; 2007 Jan 22; 22(127):62-5. PubMed ID: 17477094
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 22; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L, Shah A, Davies MJ, Rotonda J, Maccubbin D, Tribble D, Veltri E, Mitchel Y.
    Curr Med Res Opin; 2006 May 22; 22(5):823-35. PubMed ID: 16709304
    [Abstract] [Full Text] [Related]

  • 20. Lipid-lowering effects of ezetimibe and simvastatin in combination.
    Ijioma N, Robinson JG.
    Expert Rev Cardiovasc Ther; 2011 Feb 22; 9(2):131-45. PubMed ID: 21453210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.